scholarly article | Q13442814 |
P50 | author | Florence Migot-Nabias | Q37383641 |
Philippe Deloron | Q56430125 | ||
P2093 | author name string | Florence Migot-Nabias | |
Fousseyni S Touré | |||
P2860 | cites work | A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2-3)Gal- sequences of glycophorin A | Q24643787 |
A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites | Q27230065 | ||
Analysis of human antibodies to erythrocyte binding antigen 175 of Plasmodium falciparum | Q33591313 | ||
Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies | Q33761565 | ||
Plasmodium falciparum field isolates commonly use erythrocyte invasion pathways that are independent of sialic acid residues of glycophorin A | Q34002398 | ||
Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian amazon region. | Q34002481 | ||
High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria | Q34003525 | ||
Targeted disruption of an erythrocyte binding antigen in Plasmodium falciparum is associated with a switch toward a sialic acid-independent pathway of invasion | Q35162176 | ||
Host age as a determinant of naturally acquired immunity to Plasmodium falciparum | Q35846186 | ||
Comparison of immunity to malaria in Sudan and Indonesia: crisis-form versus merozoite-invasion inhibition | Q36254695 | ||
Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity | Q36943252 | ||
Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood | Q37235685 | ||
Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. | Q37331646 | ||
Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids | Q39515040 | ||
Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass | Q39823427 | ||
Baculovirus-mediated expression of Plasmodium falciparum erythrocyte binding antigen 175 polypeptides and their recognition by human antibodies | Q39830868 | ||
Biological activities of immunoglobulins of different classes and subclasses. | Q39949391 | ||
Relationships between malaria prevalence and malaria-related morbidity in school children from two villages in central Africa. | Q40635057 | ||
Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea | Q40694087 | ||
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. | Q40734085 | ||
Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications | Q40920376 | ||
Receptor and ligand domains for invasion of erythrocytes by Plasmodium falciparum. | Q41460430 | ||
Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion | Q42129581 | ||
Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes | Q42938913 | ||
Binding of Plasmodium falciparum 175-kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires N-acetylneuraminic acid but not its O-acetylated form | Q43690388 | ||
Aspects of the molecular structure of IgG subclasses. | Q43972062 | ||
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection | Q44147641 | ||
Relationships between maternal malaria and malarial immune responses in mothers and neonates | Q44198135 | ||
Sequence conservation of a functional domain of erythrocyte binding antigen 175 in Plasmodium falciparum | Q44638315 | ||
Pattern of immunoglobulin isotype response to Plasmodium falciparum blood-stage antigens in individuals living in a holoendemic area of Senegal (Dielmo, west Africa). | Q44710649 | ||
Antibodies to variable Plasmodium falciparum-infected erythrocyte surface antigens are associated with protection from novel malaria infections | Q46184700 | ||
Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria | Q46227346 | ||
Immune responses against Plasmodium falciparum asexual blood-stage antigens and disease susceptibility in Gabonese and Cameroonian children. | Q46573615 | ||
A hypothesis about the chronicity of malaria infection | Q46833996 | ||
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. | Q47830190 | ||
Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen | Q47874795 | ||
Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria. | Q47875788 | ||
Two alleles of the 175-kilodalton Plasmodium falciparum erythrocyte binding antigen | Q48112376 | ||
EBA-175: an erythrocyte-binding ligand of Plasmodium falciparum. | Q53872636 | ||
P433 | issue | 1 | |
P921 | main subject | antibody | Q79460 |
Plasmodium falciparum | Q311383 | ||
P304 | page(s) | 1-6 | |
P577 | publication date | 2006-03-01 | |
P1433 | published in | Clinical Medicine & Research | Q15757811 |
P1476 | title | Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum | |
P478 | volume | 4 |